rs104894791

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BS2_Supporting

The NM_004006.3(DMD):​c.10262C>T​(p.Ala3421Val) variant causes a missense change. The variant allele was found at a frequency of 0.000011 in 1,092,548 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A3421T) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 23)
Exomes 𝑓: 0.000011 ( 0 hom. 2 hem. )

Consequence

DMD
NM_004006.3 missense

Scores

2
7
7
Splicing: ADA: 0.9922
1
1

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts P:1U:5

Conservation

PhyloP100: 4.16

Publications

6 publications found
Variant links:
Genes affected
DMD (HGNC:2928): (dystrophin) This gene spans a genomic range of greater than 2 Mb and encodes a large protein containing an N-terminal actin-binding domain and multiple spectrin repeats. The encoded protein forms a component of the dystrophin-glycoprotein complex (DGC), which bridges the inner cytoskeleton and the extracellular matrix. Deletions, duplications, and point mutations at this gene locus may cause Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), or cardiomyopathy. Alternative promoter usage and alternative splicing result in numerous distinct transcript variants and protein isoforms for this gene. [provided by RefSeq, Dec 2016]
DMD Gene-Disease associations (from GenCC):
  • Becker muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
  • dilated cardiomyopathy 3B
    Inheritance: XL Classification: DEFINITIVE Submitted by: Ambry Genetics
  • Duchenne and Becker muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE Submitted by: Myriad Women’s Health
  • Duchenne muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • progressive muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • symptomatic form of muscular dystrophy of Duchenne and Becker in female carriers
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

BS2
High AC in GnomAdExome4 at 12 XL,AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DMDNM_004006.3 linkc.10262C>T p.Ala3421Val missense_variant Exon 71 of 79 ENST00000357033.9 NP_003997.2 P11532

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DMDENST00000357033.9 linkc.10262C>T p.Ala3421Val missense_variant Exon 71 of 79 1 NM_004006.3 ENSP00000354923.3 A0A075B6G3

Frequencies

GnomAD3 genomes
Cov.:
23
GnomAD2 exomes
AF:
0.0000112
AC:
2
AN:
179063
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000251
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000110
AC:
12
AN:
1092548
Hom.:
0
Cov.:
29
AF XY:
0.00000558
AC XY:
2
AN XY:
358562
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26318
American (AMR)
AF:
0.0000285
AC:
1
AN:
35064
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19334
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30150
South Asian (SAS)
AF:
0.0000187
AC:
1
AN:
53426
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40404
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4130
European-Non Finnish (NFE)
AF:
0.0000119
AC:
10
AN:
837775
Other (OTH)
AF:
0.00
AC:
0
AN:
45947
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.430
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
23
Alfa
AF:
0.0000304
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Pathogenic:1Uncertain:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:3
May 19, 2023
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Observed in a 13 year old male with elevated CK levels, intellectual disability, and autism in published literature (Allen et al., 2018). No additional neuromuscular or cardiac findings were observed and only analysis of the DMD gene was completed.; In silico analysis supports that this missense variant does not alter protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 29610182, 8281150, 26350204, 25525159) -

Feb 25, 2022
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 18, 2015
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Becker muscular dystrophy Pathogenic:1
Nov 01, 1993
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

not specified Uncertain:1
Nov 25, 2022
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: DMD c.10262C>T (p.Ala3421Val) results in a non-conservative amino acid change located in the Carboxy-terminal domain of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant alters the last nucleotide of exon 71 adjacent to the canonical splice donor site in Intron 71. 4/4 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 1.1e-05 in 179063 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.10262C>T has been reported in the literature in an individual with a reported diagnosis of BMD without mental retardation (Lenk_1993), Intellectual disability in the UK10K dataset (Grozeva_2015), and ID/autism with elevated CPK levels in a pediatric setting (Allen_2018). These reports do not provide unequivocal conclusions about association of the variant with Dystrophinopathies. One publication reports experimental evidence evaluating an impact on protein function and showed that this variant exhibited impaired interactions with a long noncoding RNA H19 (Zhang_2020). However, this result does not allow convincing conclusions about the pathogenic role of this variant. Three ClinVar submitters have assessed the variant since 2014: all have classified the variant as of uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. -

Duchenne muscular dystrophy Uncertain:1
Aug 31, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces alanine with valine at codon 3421 of the DMD protein (p.Ala3421Val). The alanine residue is highly conserved and there is a small physicochemical difference between alanine and valine. This variant is not present in population databases (ExAC no frequency). This missense change has been observed in individual(s) with clinical features of DMD-related conditions (PMID: 8281150, 26350204). This variant is also known as c.10238C>T (p.Ala3413Val). ClinVar contains an entry for this variant (Variation ID: 11276). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C25". The valine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.079
BayesDel_addAF
Pathogenic
0.20
D
BayesDel_noAF
Uncertain
0.050
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.26
.;T;T;.;T;.;.;.;T;.
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.84
T;.;.;T;.;T;T;T;.;T
M_CAP
Pathogenic
0.59
D
MetaRNN
Uncertain
0.43
T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
-0.10
T
PhyloP100
4.2
PrimateAI
Uncertain
0.69
T
PROVEAN
Benign
-1.2
N;.;N;.;N;.;N;N;N;N
REVEL
Uncertain
0.43
Sift
Benign
0.42
T;.;T;.;D;.;D;T;T;T
Sift4G
Benign
0.28
T;T;T;T;T;T;T;T;T;T
Polyphen
0.22, 0.95
.;.;B;.;P;.;.;.;B;.
Vest4
0.42
MutPred
0.58
.;.;.;.;.;.;Loss of glycosylation at P3422 (P = 0.0902);.;.;.;
MVP
0.96
MPC
0.066
ClinPred
0.72
D
GERP RS
4.9
PromoterAI
-0.037
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
gMVP
0.34
Mutation Taster
=6/94
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
0.99
dbscSNV1_RF
Benign
0.67
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs104894791; hg19: chrX-31196049; COSMIC: COSV58902399; COSMIC: COSV58902399; API